Cancer Research Targets Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by She, Q.-B.
Right arrow Articles by Dong, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by She, Q.-B.
Right arrow Articles by Dong, Z.
[Cancer Research 61, 1604-1610, February 15, 2001]
© 2001 American Association for Cancer Research

Molecular Biology and Genetics

Resveratrol-induced Activation of p53 and Apoptosis Is Mediated by Extracellular- Signal-regulated Protein Kinases and p38 Kinase1

Qing-Bai She, Ann M. Bode, Wei-Ya Ma, Nan-Yue Chen and Zigang Dong2

The Hormel Institute, University of Minnesota, Austin, Minnesota 55912

Resveratrol, a phytoalexin found in grapes, berries, and peanuts, is one of the most promising agents for cancer prevention. Our previous study showed that the antitumor activity of resveratrol occurs through p53-mediated apoptosis. In this study, we have elucidated the potential signaling components underlying resveratrol-induced p53 activation and induction of apoptosis. We found that in a mouse JB6 epidermal cell line, resveratrol activated extracellular-signal-regulated protein kinases (ERKs), c-Jun NH2-terminal kinases (JNKs), and p38 kinase and induced serine 15 phosphorylation of p53. Stable expression of a dominant negative mutant of ERK2 or p38 kinase or their respective inhibitor, PD98059 or SB202190, repressed the phosphorylation of p53 at serine 15. In contrast, overexpression of a dominant negative mutant of JNK1 had no effect on the phosphorylation. Most importantly, ERKs and p38 kinase formed a complex with p53 after treatment with resveratrol. Strikingly, resveratrol-activated ERKs and p38 kinase, but not JNKs, phosphorylated p53 at serine 15 in vitro. Furthermore, pretreatment of the cells with PD98059 or SB202190 or stable expression of a dominant negative mutant of ERK2 or p38 kinase impaired resveratrol-induced p53-dependent transcriptional activity and apoptosis, whereas constitutively active MEK1 increased the transcriptional activity of p53. These data strongly suggest that both ERKs and p38 kinase mediate resveratrol-induced activation of p53 and apoptosis through phosphorylation of p53 at serine 15.




This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
A. Saleem, P. J. Adhihetty, and D. A. Hood
Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle
Physiol Genomics, March 3, 2009; 37(1): 58 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
T. S. Udayakumar, P. Hachem, M. M. Ahmed, S. Agrawal, and A. Pollack
Antisense MDM2 Enhances E2F1-Induced Apoptosis and the Combination Sensitizes Androgen-Dependent and Androgen-Independent Prostate Cancer Cells to Radiation
Mol. Cancer Res., November 1, 2008; 6(11): 1742 - 1754.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Hu, H.-J. Lee, C. Jiang, J. Zhang, L. Wang, Y. Zhao, Q. Xiang, E.-O. Lee, S.-H. Kim, and J. Lu
Penta-1,2,3,4,6-O-galloyl-{beta}-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo
Mol. Cancer Ther., September 1, 2008; 7(9): 2681 - 2691.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Shim and T. E. Eling
Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism
Mol. Cancer Ther., April 1, 2008; 7(4): 961 - 971.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. W. Lee, N. J. Kang, Y.-S. Heo, E. A. Rogozin, A. Pugliese, M. K. Hwang, G. T. Bowden, A. M. Bode, H. J. Lee, and Z. Dong
Raf and MEK Protein Kinases Are Direct Molecular Targets for the Chemopreventive Effect of Quercetin, a Major Flavonol in Red Wine
Cancer Res., February 1, 2008; 68(3): 946 - 955.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. Rayalam, M. A. Della-Fera, J.-Y. Yang, H. J. Park, S. Ambati, and C. A. Baile
Resveratrol Potentiates Genistein's Antiadipogenic and Proapoptotic Effects in 3T3-L1 Adipocytes
J. Nutr., December 1, 2007; 137(12): 2668 - 2673.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. W. Lee, N. J. Kang, E. A. Rogozin, H.-G. Kim, Y. Y. Cho, A. M. Bode, H. J. Lee, Y.-J. Surh, G. T. Bowden, and Z. Dong
Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1
Carcinogenesis, September 1, 2007; 28(9): 1918 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ulrich, S. M. Loitsch, O. Rau, A. von Knethen, B. Brune, M. Schubert-Zsilavecz, and J. M. Stein
Peroxisome Proliferator-Activated Receptor {gamma} as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism.
Cancer Res., July 15, 2006; 66(14): 7348 - 7354.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Mohan, A. A. Gandhi, B. C. Bhavya, R. Rashmi, D. Karunagaran, R. Indu, and T. R. Santhoshkumar
Caspase-2 Triggers Bax-Bak-dependent and -independent Cell Death in Colon Cancer Cells Treated with Resveratrol
J. Biol. Chem., June 30, 2006; 281(26): 17599 - 17611.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Das, A. Tosaki, D. Bagchi, N. Maulik, and D. K. Das
Potentiation of a Survival Signal in the Ischemic Heart by Resveratrol through p38 Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1/cAMP Response Element-Binding Protein Signaling
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 980 - 988.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. J. Mukherjee and H. C. Sikka
Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NF{kappa}B activation: role of p38 MAP kinase
Carcinogenesis, March 1, 2006; 27(3): 631 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
O. Kutuk, G. Poli, and H. Basaga
Resveratrol Protects Against 4-Hydroxynonenal-Induced Apoptosis by Blocking JNK and c-JUN/AP-1 Signaling
Toxicol. Sci., March 1, 2006; 90(1): 120 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Q. Zhang, X. Tang, Q. Y. Lu, Z. F. Zhang, J. Brown, and A. D. Le
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1{alpha} and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells
Mol. Cancer Ther., October 1, 2005; 4(10): 1465 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J.-S. Kim, S. J. Baek, F. G. Bottone Jr., T. Sali, and T. E. Eling
Overexpression of 15-Lipoxygenase-1 Induces Growth Arrest through Phosphorylation of p53 in Human Colorectal Cancer Cells
Mol. Cancer Res., September 1, 2005; 3(9): 511 - 517.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. B. Friis, C. R. Friborg, L. Schneider, M.-B. Nielsen, I. H. Lambert, S. T. Christensen, and E. K. Hoffmann
Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts
J. Physiol., September 1, 2005; 567(2): 427 - 443.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Dhanalakshmi, C. Agarwal, R. P. Singh, and R. Agarwal
Silibinin Up-regulates DNA-Protein Kinase-dependent p53 Activation to Enhance UVB-induced Apoptosis in Mouse Epithelial JB6 Cells
J. Biol. Chem., May 27, 2005; 280(21): 20375 - 20383.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y.-L. Hsu, P.-L. Kuo, L.-T. Lin, and C.-C. Lin
Asiatic Acid, a Triterpene, Induces Apoptosis and Cell Cycle Arrest through Activation of Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Pathways in Human Breast Cancer Cells
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 333 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Jiang, L. Zhang, J. Kuo, K. Kuo, S. C. Gautam, L. Groc, A. I. Rodriguez, D. Koubi, T. Jackson Hunter, G. B. Corcoran, et al.
Resveratrol-induced apoptotic death in human U251 glioma cells
Mol. Cancer Ther., April 1, 2005; 4(4): 554 - 561.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. U. Mertens-Talcott, J. A. Bomser, C. Romero, S. T. Talcott, and S. S. Percival
Ellagic Acid Potentiates the Effect of Quercetin on p21waf1/cip1, p53, and MAP-Kinases without Affecting Intracellular Generation of Reactive Oxygen Species In Vitro
J. Nutr., March 1, 2005; 135(3): 609 - 614.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Yang and F. L. Meyskens Jr.
Alterations in Activating Protein 1 Composition Correlate with Phenotypic Differentiation Changes Induced by Resveratrol in Human Melanoma
Mol. Pharmacol., January 1, 2005; 67(1): 298 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Arora, I. A. Siddiqui, and Y. Shukla
Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice
Mol. Cancer Ther., November 1, 2004; 3(11): 1459 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Jiang, H. Hu, B. Malewicz, Z. Wang, and J. Lu
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells
Mol. Cancer Ther., July 1, 2004; 3(7): 877 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-H. Tseng, S.-M. Lin, J.-C. Chen, Y.-H. Su, H.-Y. Huang, C.-K. Chen, P.-Y. Lin, and Y. Chen
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Clin. Cancer Res., March 15, 2004; 10(6): 2190 - 2202.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. A. Ahmad, M.-V. Clement, I. M. Hanif, and S. Pervaiz
Resveratrol Inhibits Drug-Induced Apoptosis in Human Leukemia Cells by Creating an Intracellular Milieu Nonpermissive for Death Execution
Cancer Res., February 15, 2004; 64(4): 1452 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. PERVAIZ
Resveratrol: from grapevines to mammalian biology
FASEB J, November 1, 2003; 17(14): 1975 - 1985.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, et al.
Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells
J. Biol. Chem., October 17, 2003; 278(42): 41482 - 41490.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Gescher and W. P. Steward
Relationship between Mechanisms, Bioavailibility, and Preclinical Chemopreventive Efficacy of Resveratrol: A Conundrum
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 953 - 957.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. He, W.-Y. Ma, T. Hashimoto, A. M. Bode, C. S. Yang, and Z. Dong
Induction of Apoptosis by Caffeine Is Mediated by the p53, Bax, and Caspase 3 Pathways
Cancer Res., August 1, 2003; 63(15): 4396 - 4401.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. M. Brownson, N. G. Azios, B. K. Fuqua, S. F. Dharmawardhane, and T. J. Mabry
Flavonoid Effects Relevant to Cancer
J. Nutr., November 1, 2002; 132(11): 3482S - 3489.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z. G. Li, T. Hong, Y. Shimada, I. Komoto, A. Kawabe, Y. Ding, J. Kaganoi, Y. Hashimoto, and M. Imamura
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol
Carcinogenesis, September 1, 2002; 23(9): 1531 - 1536.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal
Suppression of 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogenesis in Rats by Resveratrol: Role of Nuclear Factor-{kappa}B, Cyclooxygenase 2, and Matrix Metalloprotease 9
Cancer Res., September 1, 2002; 62(17): 4945 - 4954.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
F. G. Bottone Jr., S. J. Baek, J. B. Nixon, and T. E. Eling
Diallyl Disulfide (DADS) Induces the Antitumorigenic NSAID-Activated Gene (NAG-1) by a p53-Dependent Mechanism in Human Colorectal HCT 116 Cells
J. Nutr., April 1, 2002; 132(4): 773 - 778.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. J. Baek, L. C. Wilson, and T. E. Eling
Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53
Carcinogenesis, March 1, 2002; 23(3): 425 - 432.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-W. Kwon, S. Ueda, M. Ueno, J. Yodoi, and H. Masutani
Mechanism of p53-dependent Apoptosis Induced by 3-Methylcholanthrene. INVOLVEMENT OF p53 PHOSPHORYLATION AND p38 MAPK
J. Biol. Chem., January 11, 2002; 277(3): 1837 - 1844.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Cuda, R. Paterno, R. Ceravolo, M. Candigliota, N. Perrotti, F. Perticone, M. C. Faniello, F. Schepis, A. Ruocco, E. Mele, et al.
Protection of Human Endothelial Cells From Oxidative Stress: Role of Ras-ERK1/2 Signaling
Circulation, February 26, 2002; 105(8): 968 - 974.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.